Comparison of two kinds of topical drugs in treatment of dermatological infections

Phase 3

• Conditions: Condition 1: Dermatophytosis. Condition 2: ?uperficial staphylococcal-streptococcal skin infections.; Dermatophytosis, unspecified; Streptococcal infection, unspecified site

• Registration Number: IRCT201401045092N2
• Lead Sponsor: Vice chancellor for research, Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

superficial staphylococcal-streptococcal skin infections; age more than 4 years old; not having immune disorder and organ failure; not having history of allergy to silver compounds and clotrimasole; not using topical drugs in last two weeks in the site of lesion.
Exclusion criteria: unwillingness to continue participation in the study, occurring a dermatological reaction due to drugs administered; any kind of drug reaction.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Erythema. Timepoint: Before starting the study and at the end of study. Method of measurement: Clinical evaluation and grading based on complete treatment, partial treatment and no treatment.;Encrustation. Timepoint: Before starting the study and at the end of study. Method of measurement: Clinical evaluation and grading based on complete treatment, partial treatment and no treatment.;Inflammation. Timepoint: Before starting the study and at the end of study. Method of measurement: Clinical evaluation and grading based on complete treatment, partial treatment and no treatment.;Exudation. Timepoint: Before starting the study and at the end of study. Method of measurement: Clinical evaluation and grading based on complete treatment, partial treatment and no treatment.